Literature DB >> 23142755

Oxidative DNA damage of peripheral blood polymorphonuclear leukocytes, selectively induced by chronic arsenic exposure, is associated with extent of arsenic-related skin lesions.

Qiuling Pei1, Ning Ma, Jing Zhang, Wenchao Xu, Yong Li, Zhifeng Ma, Yunyun Li, Fengjie Tian, Wenping Zhang, Jinjun Mu, Yuanfei Li, Dongxing Wang, Haifang Liu, Mimi Yang, Caifeng Ma, Fen Yun.   

Abstract

There is increasing evidence that oxidative stress is an important risk factor for arsenic-related diseases. Peripheral blood leukocytes constitute an important defense against microorganisms or pathogens, while the research on the impact of chronic arsenic exposure on peripheral blood leukocytes is much more limited, especially at low level arsenic exposure. The purpose of the present study was to explore whether chronic arsenic exposure affects oxidative stress of peripheral blood leukocytes and possible linkages between oxidative stress and arsenic-induced skin lesions. 75 male inhabitants recruited from an As-endemic region of China were investigated in the present study. The classification of arsenicosis was based on the degree of skin lesions. Arsenic levels were measured in drinking water and urine by Atomic Fluorescence Spectroscopy. Urinary 8-hydroxy-2'-deoxyguanosine (8-OHdG) was tested by Enzyme-Linked Immunosorbent Assay. 8-OHdG of peripheral blood leukocytes was evaluated using immunocytochemical staining. 8-OHdG-positive reactions were only present in polymorphonuclear leukocytes (PMNs), but not in monocytes (MNs). The 8-OHdG staining of PMN cytoplasm was observed in all investigated populations, while the 8-OHdG staining of PMN nuclei was frequently found along with the elevated amounts of cell debris in individuals with skin lesion. Urinary arsenic levels were increased in the severe skin lesion group compared with the normal group. No relationship was observed between drinking water arsenic or urine 8-OHdG and the degree of skin lesions. These findings indicated that the target and persistent oxidative stress in peripheral blood PMNs may be employed as a sensitive biomarker directly to assess adverse health effects caused by chronic exposure to lower levels of arsenic.
Copyright © 2012. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23142755     DOI: 10.1016/j.taap.2012.10.031

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  5 in total

1.  Metal exposure and oxidative stress markers in pregnant Navajo Birth Cohort Study participants.

Authors:  Erica J Dashner-Titus; Joseph Hoover; Luo Li; Ji-Hyun Lee; Ruofei Du; Ke Jian Liu; Maret G Traber; Emily Ho; Johnnye Lewis; Laurie G Hudson
Journal:  Free Radic Biol Med       Date:  2018-04-30       Impact factor: 7.376

2.  Gene-arsenic interaction in longitudinal changes of blood pressure: Findings from the Health Effects of Arsenic Longitudinal Study (HEALS) in Bangladesh.

Authors:  Shohreh F Farzan; Margaret R Karagas; Jieying Jiang; Fen Wu; Mengling Liu; Jonathan D Newman; Farzana Jasmine; Muhammad G Kibriya; Rachelle Paul-Brutus; Faruque Parvez; Maria Argos; Molly Scannell Bryan; Mahbub Eunus; Alauddin Ahmed; Tariqul Islam; Muhammad Rakibuz-Zaman; Rabiul Hasan; Golam Sarwar; Vesna Slavkovich; Joseph Graziano; Habibul Ahsan; Yu Chen
Journal:  Toxicol Appl Pharmacol       Date:  2015-07-26       Impact factor: 4.219

Review 3.  The mechanistic basis of arsenicosis: pathogenesis of skin cancer.

Authors:  Katherine M Hunt; Ritesh K Srivastava; Craig A Elmets; Mohammad Athar
Journal:  Cancer Lett       Date:  2014-08-27       Impact factor: 8.679

Review 4.  Arsenic-induced genotoxicity and genetic susceptibility to arsenic-related pathologies.

Authors:  Francesca Faita; Liliana Cori; Fabrizio Bianchi; Maria Grazia Andreassi
Journal:  Int J Environ Res Public Health       Date:  2013-04-12       Impact factor: 3.390

Review 5.  Arsenic-Induced Carcinogenesis and Immune Dysregulation.

Authors:  Hsin-Wei Huang; Chih-Hung Lee; Hsin-Su Yu
Journal:  Int J Environ Res Public Health       Date:  2019-08-01       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.